Correction to Lancet Psychiatry 2025; 12: 276-88
- PMID: 40315874
- DOI: 10.1016/S2215-0366(25)00133-6
Correction to Lancet Psychiatry 2025; 12: 276-88
Erratum for
-
Clinical and cost-effectiveness of lithium versus quetiapine augmentation for treatment-resistant depression: a pragmatic, open-label, parallel-group, randomised controlled superiority trial in the UK.Lancet Psychiatry. 2025 Apr;12(4):276-288. doi: 10.1016/S2215-0366(25)00028-8. Lancet Psychiatry. 2025. PMID: 40113355 Clinical Trial.
Publication types
LinkOut - more resources
Full Text Sources